re: Ann: Lilly and Acrux file lawsuit against... Andrew.I think the fact that jon Pilcher is leaving Acrux for neuren probably tell everyone that he sees more potential in neuren compared with Acrux.I have been a very happy investor in Acrux but decided to move on around the $4.00 mark.I would have thought that Eli Lilly expectations on market share would have been at least 20 percent at this stage however this has been very difficult to achieve and they are spending heaps on marketing at this stage.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.8¢ |
Change
-0.001(5.26%) |
Mkt cap ! $7.339M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.8¢ | $11.58K | 619.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 335415 | 1.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 516258 | 1 |
View Market Depth
| Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
| ACR (ASX) Chart |